AR065785A1 - Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro - Google Patents
Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierroInfo
- Publication number
- AR065785A1 AR065785A1 ARP080101125A ARP080101125A AR065785A1 AR 065785 A1 AR065785 A1 AR 065785A1 AR P080101125 A ARP080101125 A AR P080101125A AR P080101125 A ARP080101125 A AR P080101125A AR 065785 A1 AR065785 A1 AR 065785A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- independently
- alkyl
- hydrogen
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicacion 1: Un compuesto de la formula (1), caracterizado porque n y m son cada uno, de modo independiente, 1, 2, 3, 4, 5, 6 o 7; el anillo A y B son cada uno, de modo independiente, arilo o heteroarilo; R1 es un enlace directo, -O-, -S(O)p- (donde p es 0, 1 o 2), -C(R4)2-, C(O)- o -N(R4)-; al menos un R2 y al menos un R3 está seleccionado, de modo independiente, del grupo que consiste en -R6-S-C(=NR4)N(R4)R5, -R6-S-C(=NR4)N(R4)N(R4)R5, -R6-O-C(=NR4)N(R4)R5, -R6-C(O)-N=C[N(R4)(R5)]N(R4)R5, -R6-C(=NR4)N(R4)R5, -R6-C(=NCN)N(R4)R5 y -R6-N(R7)C(=NR4)N(R4)R5; y los otros R2 y R3, de estar presentes, están seleccionados cada uno, de modo independiente, del grupo que consiste en alquilo, halo, haloalquilo, -R6-OR7, -R6-CN, -R6-NO2, -R6-N(R8)2, -R-C(O)OR8, -R6-C(O)N(R8)2, -N(R8)S(O)tR9, -S(O)tOR9, -S(O)pR8, -S(O)tN(R8)2, -R6-S-C(=NR4)N(R4)R5, -R6-O-C(=NR4)N(R4)R5, -R6-C(=NR4)N(R4)R5, y -R6-N(R7)-C(=NR4)N(R4)R5, en donde cada t es, de modo independiente 1 o 2 y cada p es 0, 1 o 2; cada R4 y R5 es, de modo independiente, hidrogeno, alquilo, arilo opcionalmente sustituido, aralquilo opcionalmente sustituido, cicloalquilo opcionalmente sustituido, heterociclilo opcionalmente sustituido, heteroarilo opcionalmente sustituido o heteroaralquilo opcionalmente sustituido; cada R6 es, de modo independiente, un enlace directo o una cadena de alquileno lineal o ramificada; cada R7 es hidrogeno, alquilo, alquenilo, alquinilo, haloalquilo, alcoxialquilo, cicloalquilo opcionalmente sustituido, cicloalquilalquilo opcionalmente sustituido, arilo opcionalmente sustituido, aralquilo opcionalmente sustituido, heterociclilo opcionalmente sustituido, heterociclilalquilo opcionalmente sustituido, heteroarilo opcionalmente sustituido o heteroarilalquilo opcionalmente sustituido; cada R8 es, de modo independiente, hidrogeno o alquilo; y cada R9 es alquilo; en forma de uno de sus estereoisomeros, enantiomeros, tautomeros o sus mezclas; o una de sus sales solvatos o profármacos farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89566207P | 2007-03-19 | 2007-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR065785A1 true AR065785A1 (es) | 2009-07-01 |
Family
ID=39551662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101125A AR065785A1 (es) | 2007-03-19 | 2008-03-18 | Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080234384A1 (es) |
EP (1) | EP2061754A1 (es) |
JP (1) | JP2010522197A (es) |
CN (1) | CN101622227A (es) |
AR (1) | AR065785A1 (es) |
AU (1) | AU2008228898A1 (es) |
BR (1) | BRPI0809272A2 (es) |
CA (1) | CA2678949A1 (es) |
CL (1) | CL2008000794A1 (es) |
MX (1) | MX2009010083A (es) |
RU (1) | RU2009138351A (es) |
TW (1) | TW200843733A (es) |
WO (1) | WO2008115999A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010005851A1 (en) * | 2008-07-08 | 2010-01-14 | Xenon Pharmaceuticals Inc. | Combination therapy for treating iron disorders |
WO2010098866A1 (en) | 2009-02-27 | 2010-09-02 | Supergen, Inc. | Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors |
GB0903482D0 (en) * | 2009-02-27 | 2009-04-08 | Ucl Business Plc | New compounds |
JP2013502399A (ja) | 2009-08-20 | 2013-01-24 | ヴィフォール (インターナショナル) アクチェンゲゼルシャフト | 新規なキノリン系ヘプシジン拮抗薬 |
AR077958A1 (es) | 2009-08-27 | 2011-10-05 | Vifor Int Ag | Quinoxalinonas antagonistas de la hepcidina |
AR077999A1 (es) | 2009-09-02 | 2011-10-05 | Vifor Int Ag | Antagonistas de pirimidin y triazin-hepcidina |
JP2013503835A (ja) | 2009-09-07 | 2013-02-04 | ヴィフォール (インターナショナル) アクチェンゲゼルシャフト | 新規なエタンジアミン系ヘプシジン拮抗薬 |
WO2011029832A1 (de) | 2009-09-09 | 2011-03-17 | Vifor (International) Ag | Neue thiazol- und oxazol-hepcidin-antagonisten |
US20120214803A1 (en) | 2011-02-18 | 2012-08-23 | Vifor (International) Ag | Novel Sulfonaminoquinoline Hepcidin Antagonists |
CN103073528A (zh) * | 2012-12-21 | 2013-05-01 | 北京万全德众医药生物技术有限公司 | 草酸艾司西酞普兰杂质a的制备方法 |
CN104370784B (zh) * | 2014-12-11 | 2017-02-22 | 北京彤程创展科技有限公司 | 一种环烷基硫化锌化合物及其制备方法 |
TWI722031B (zh) | 2015-10-23 | 2021-03-21 | 瑞士商威佛(國際)股份有限公司 | 新穎的膜鐵運輸蛋白(ferroportin)抑制劑 |
JOP20180036A1 (ar) | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
TW202102478A (zh) | 2019-04-01 | 2021-01-16 | 瑞士商威佛(國際)股份有限公司 | 新穎的鐵螯合物 |
WO2024035268A2 (en) * | 2022-08-10 | 2024-02-15 | Qatar Foundation For Education, Science And Community Development | Tau pathway modulators |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2906773A (en) * | 1957-08-01 | 1959-09-29 | Dow Chemical Co | 2, 2'-oxybis (p-phenylenemethylene) bis (2-thiopseudourea) compounds |
US3247035A (en) * | 1962-09-28 | 1966-04-19 | Standard Oil Co | Ammonium nitrate propellants containing a nitro-aminocarboxy-alkali metal phenolate combustion catalyst |
NL134627C (es) * | 1966-10-27 | |||
FR1541946A (fr) * | 1966-10-27 | 1968-10-11 | Geigy Ag J R | Amines et produits d'entretien des surfaces contenant ces amines |
US3636109A (en) * | 1969-02-05 | 1972-01-18 | Dow Chemical Co | 2 2'-isopropylidenebis((6 - lower alkoxy-m-phenylene)methylene)bis(2 - thiopseudourea) dihydrochlori |
JPH0791260B2 (ja) * | 1986-12-27 | 1995-10-04 | 第一製薬株式会社 | グアニジン誘導体及びその塩 |
IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
DE19603425A1 (de) * | 1996-01-31 | 1997-08-07 | Hoechst Ag | Substituierte Diaryldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10024319A1 (de) * | 2000-05-17 | 2001-11-22 | Merck Patent Gmbh | Bisacylguanidine |
DE60118754T2 (de) * | 2000-08-08 | 2007-01-11 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclische verbindungen als h3 rezeptor liganden |
EP2068855A2 (en) * | 2007-06-05 | 2009-06-17 | Xenon Pharmaceuticals Inc. | Aromatic and heteroaromatic compounds useful in treating iron disorders |
-
2008
- 2008-03-18 AR ARP080101125A patent/AR065785A1/es not_active Application Discontinuation
- 2008-03-19 BR BRPI0809272-9A2A patent/BRPI0809272A2/pt not_active IP Right Cessation
- 2008-03-19 TW TW097109658A patent/TW200843733A/zh unknown
- 2008-03-19 JP JP2009554715A patent/JP2010522197A/ja not_active Withdrawn
- 2008-03-19 AU AU2008228898A patent/AU2008228898A1/en not_active Abandoned
- 2008-03-19 WO PCT/US2008/057519 patent/WO2008115999A1/en active Application Filing
- 2008-03-19 EP EP08744072A patent/EP2061754A1/en not_active Withdrawn
- 2008-03-19 CA CA002678949A patent/CA2678949A1/en not_active Abandoned
- 2008-03-19 RU RU2009138351/04A patent/RU2009138351A/ru not_active Application Discontinuation
- 2008-03-19 MX MX2009010083A patent/MX2009010083A/es unknown
- 2008-03-19 CN CN200880006800A patent/CN101622227A/zh active Pending
- 2008-03-19 CL CL200800794A patent/CL2008000794A1/es unknown
- 2008-03-19 US US12/051,741 patent/US20080234384A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CL2008000794A1 (es) | 2008-05-30 |
AU2008228898A1 (en) | 2008-09-25 |
EP2061754A1 (en) | 2009-05-27 |
RU2009138351A (ru) | 2011-04-27 |
JP2010522197A (ja) | 2010-07-01 |
CA2678949A1 (en) | 2008-09-25 |
TW200843733A (en) | 2008-11-16 |
WO2008115999A8 (en) | 2008-12-24 |
US20080234384A1 (en) | 2008-09-25 |
BRPI0809272A2 (pt) | 2014-10-14 |
MX2009010083A (es) | 2009-10-12 |
CN101622227A (zh) | 2010-01-06 |
WO2008115999A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR065785A1 (es) | Compuestos biarilo y biheteroarilo de utilidad en el tratamiento de trastornos de hierro | |
AR058546A1 (es) | Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1 | |
AR077267A1 (es) | Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes. | |
AR059314A1 (es) | Derivados de las benzamidas y heteroarenos | |
AR043014A1 (es) | Amino-1,3,5-triazinas n-sustituidas con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas, y su uso como herbicidas y reguladores del crecimiento de las plantas | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
CO4810382A1 (es) | Compuestos de indol agentes anti-inflamatorios/analgesicos | |
AR083169A1 (es) | Compuestos para tratar enfermedades neurodegenerativas | |
AR043700A1 (es) | Derivados de 3-substituida-4-pirimidona | |
AR087995A1 (es) | Derivados de n-(4-{[6,7-bis(metiloxi)quinolin-4-il]oxi}fenil)-n-(4-fluorofenil)ciclopropan-1,1-dicarboxamida | |
PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
CR10250A (es) | Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g | |
JO3530B1 (ar) | مركبات بيريدازين 1،4-ثنائية الإرتباط ونظائرها وطرق معالجة نقص smn وحالاته المرضية. | |
DOP2012000149A (es) | Compuestos triciclicos novedosos | |
AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
AR065815A1 (es) | Compuestos de dihidroindazol en el tratamiento de trastornos del hierro | |
CO6290763A2 (es) | Derivados de benzamidas, carboxamidas y nicotinamidas como moduladores alostericos positivos y sus composiciones | |
AR062409A1 (es) | Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto | |
AR066972A1 (es) | Derivados azapeptidicos | |
AR082111A1 (es) | Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas | |
AR100715A1 (es) | Derivados de alquilo de compuestos 1-oxa-4,9-diazaespiro undeceno que tienen actividad multimodal contra el dolor | |
EA201792597A2 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
BR112018069712A2 (pt) | composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a. | |
PH12015502429A1 (en) | Dicarboxylic acid compound | |
UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |